Skip to Content

Zhejiang Dayang Biotech Group No. 22, China, 2025

GMP Audit Report

Company
Zhejiang Dayang Biotech Group No. 22

Product(s)
Amprolium

Country
China

Audit Year
2025


This product is no longer available.